Real Heart (HEART) - Net Assets

Latest as of June 2025: Skr74.35 Million SEK ≈ $8.00 Million USD

Based on the latest financial reports, Real Heart (HEART) has net assets worth Skr74.35 Million SEK (≈ $8.00 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr87.94 Million ≈ $9.46 Million USD) and total liabilities (Skr13.59 Million ≈ $1.46 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Real Heart tangible book value ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr74.35 Million
% of Total Assets	84.54%
Annual Growth Rate	36.11%
5-Year Change	-6.07%
10-Year Change	1028.55%
Growth Volatility	331.37

Real Heart - Net Assets Trend (2010–2024)

This chart illustrates how Real Heart's net assets have evolved over time, based on quarterly financial data. See Real Heart liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Real Heart (2010–2024)

The table below shows the annual net assets of Real Heart from 2010 to 2024. For live valuation and market cap data, see market cap of Real Heart.

Year	Net Assets	Change
2024-12-31	Skr67.34 Million ≈ $7.25 Million	-17.92%
2023-12-31	Skr82.04 Million ≈ $8.83 Million	-15.98%
2022-12-31	Skr97.65 Million ≈ $10.51 Million	-12.26%
2021-12-31	Skr111.29 Million ≈ $11.98 Million	+55.23%
2020-12-31	Skr71.69 Million ≈ $7.72 Million	+21.51%
2019-12-31	Skr59.00 Million ≈ $6.35 Million	+205.70%
2018-12-31	Skr19.30 Million ≈ $2.08 Million	-29.87%
2017-12-31	Skr27.52 Million ≈ $2.96 Million	+69.86%
2016-12-31	Skr16.20 Million ≈ $1.74 Million	+171.52%
2015-12-31	Skr5.97 Million ≈ $642.14K	-20.41%
2014-12-31	Skr7.50 Million ≈ $806.85K	+1285.74%
2013-12-31	Skr541.04K ≈ $58.22K	-32.25%
2012-12-31	Skr798.57K ≈ $85.94K	-1.66%
2011-12-31	Skr812.04K ≈ $87.39K	-9.64%
2010-12-31	Skr898.64K ≈ $96.71K	--

Equity Component Analysis

This analysis shows how different components contribute to Real Heart's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 16960153800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	Skr10.36 Million	15.39%
Other Components	Skr226.66 Million	336.59%
Total Equity	Skr67.34 Million	100.00%

Real Heart Competitors by Market Cap

The table below lists competitors of Real Heart ranked by their market capitalization.

Company	Market Cap
Garovaglio y Zorraquin S.A. BA:GARO	$12.48 Million
Property Perfect Public Company Limited BK:PF	$12.48 Million
Grand Pacific Petrochemical Corp Pref TW:1312A	$12.49 Million
Park & Bellheimer AG F:PKB	$12.50 Million
Vizione Holdings Bhd KLSE:7070	$12.48 Million
SeaStar Medical Holding Corporation NASDAQ:ICU	$12.47 Million
Gaxos.ai Inc NASDAQ:GXAI	$12.47 Million
Mustera Property Group Ltd AU:MPX	$12.47 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Real Heart's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 82,037,974 to 67,340,121, a change of -14,697,853 (-17.9%).
Net loss of 34,350,000 reduced equity.
New share issuances of 19,585,388 increased equity.
Other comprehensive income increased equity by 138,814,289.
Other factors decreased equity by 138,747,530.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Skr-34.35 Million	-51.01%
Share Issuances	Skr19.59 Million	+29.08%
Other Comprehensive Income	Skr138.81 Million	+206.14%
Other Changes	Skr-138.75 Million	-206.04%
Total Change	Skr-	-17.92%

Book Value vs Market Value Analysis

This analysis compares Real Heart's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.71x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 443.00x to 0.71x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2010-12-31	Skr0.05	Skr23.20	x
2011-12-31	Skr0.05	Skr23.20	x
2012-12-31	Skr0.05	Skr23.20	x
2013-12-31	Skr0.03	Skr23.20	x
2014-12-31	Skr0.44	Skr23.20	x
2015-12-31	Skr0.35	Skr23.20	x
2016-12-31	Skr0.86	Skr23.20	x
2017-12-31	Skr1.20	Skr23.20	x
2018-12-31	Skr0.86	Skr23.20	x
2019-12-31	Skr208.01	Skr23.20	x
2020-12-31	Skr206.17	Skr23.20	x
2021-12-31	Skr2.24	Skr23.20	x
2022-12-31	Skr131.65	Skr23.20	x
2023-12-31	Skr56.66	Skr23.20	x
2024-12-31	Skr32.56	Skr23.20	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Real Heart utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -51.01%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.00%
• Asset Turnover: 0.00x
• Equity Multiplier: 1.24x
Recent ROE (-51.01%) is below the historical average (-28.22%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2010	-13.00%	-973258.33%	0.00x	1.08x	Skr-206.65K
2011	-10.66%	-8659500.00%	0.00x	1.08x	Skr-167.80K
2012	-1.69%	0.00%	0.00x	1.55x	Skr-93.33K
2013	-47.69%	-58239.28%	0.00x	2.56x	Skr-312.10K
2014	-22.54%	-746.94%	0.03x	1.11x	Skr-2.44 Million
2015	-25.66%	-1034.08%	0.02x	1.11x	Skr-2.13 Million
2016	-23.97%	-2927.48%	0.01x	1.25x	Skr-5.50 Million
2017	-49.94%	-1773.49%	0.02x	1.23x	Skr-16.50 Million
2018	-45.89%	-7955.31%	0.00x	1.42x	Skr-10.79 Million
2019	-12.36%	0.00%	0.00x	1.13x	Skr-13.19 Million
2020	-12.30%	0.00%	0.00x	1.09x	Skr-15.99 Million
2021	-9.42%	0.00%	0.00x	1.06x	Skr-21.61 Million
2022	-14.33%	-139880.00%	0.00x	1.23x	Skr-23.75 Million
2023	-82.86%	0.00%	0.00x	1.25x	Skr-76.18 Million
2024	-51.01%	0.00%	0.00x	1.24x	Skr-41.08 Million

Industry Comparison

This section compares Real Heart's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $154,871,216
Average return on equity (ROE) among peers: -59.99%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Real Heart (HEART)	Skr74.35 Million	-13.00%	0.18x	$12.48 Million
Acarix A/S (ACARIX)	$100.54 Million	-51.52%	0.18x	$31.21 Million
Arcoma AB (ARCOMA)	$49.53 Million	2.76%	0.92x	$13.61 Million
Bactiguard Holding AB (publ) (BACTI-B)	$387.11 Million	-0.84%	0.62x	$54.96 Million
BICO Group AB (BICO)	$549.64 Million	0.11%	0.10x	$124.14 Million
Boule Diagnostics AB (BOUL)	$192.86 Million	6.07%	0.41x	$13.37 Million
CellaVision AB (CEVI)	$206.18 Million	29.00%	0.24x	$351.14 Million
Clinical Laserthermia Systems AB (publ) (CLS-B)	$3.68 Million	-18.24%	0.50x	$11.99 Million
Chordate Medical Holding AB (CMH)	$15.09 Million	-193.46%	0.46x	$29.05K
C-Rad AB (publ) (CRAD-B)	$38.03 Million	-55.21%	0.62x	$127.56 Million
Duearity AB (DEAR)	$6.06 Million	-318.56%	0.99x	$331.97K

About Real Heart

ST:HEART Sweden Medical Devices

Market Cap

$12.48 Million

Skr115.97 Million SEK

Market Cap Rank

#26485 Global

#570 in Sweden

Share Price

Skr23.20

Change (1 day)

+1.75%

52-Week Range

Skr13.00 - Skr29.00

All Time High

Skr1625.78